Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1121A | ISIN: US45781A1079 | Ticker-Symbol:
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
INSTITUTE OF BIOMEDICAL RESEARCH CORP Chart 1 Jahr
5-Tage-Chart
INSTITUTE OF BIOMEDICAL RESEARCH CORP 5-Tage-Chart

Aktuelle News zur INSTITUTE OF BIOMEDICAL RESEARCH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrInstitute of BioMedical Research Corp.: MRES: M2Bio Food and Beverage Wraps Up 2023/ 2024 Looking Ahead401CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specialising in alternative...
► Artikel lesen
01.03.Institute of BioMedical Research Corp.: MRES: M2Bio Sciences Provides Corporate Update276CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / March 1, 2024 / Institute of Biomedical Research Corporation (OTC PINK:MRES) is pleased to provide further details of the sale to Real American Capital Corporation...
► Artikel lesen
23.02.Institute of BioMedical Research Corp.: MRES: M2Bio Sciences Introduces M2BioKids: A Pioneering Approach to Elevating Childhood Health and Development501CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 23, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in...
► Artikel lesen
22.02.Institute of BioMedical Research Corp.: MRES: M2Enviro 2023 Year-End Review and 2024 Looking Forward640CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 22, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology,specializing in alternative...
► Artikel lesen
09.02.Institute of BioMedical Research Corp.: MRES: M2Biome 2023 Year-End Review and 2024 Looking Forward376CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / February 9, 2024 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alternative...
► Artikel lesen
02.01.Institute of BioMedical Research Corp.: MRES: M2MMA Gears Up for a Landmark Year in 2024796CAPE TOWN / ACCESSWIRE / January 2, 2024 / CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / January 2, 2024 / Institute of Biomedical Research Corp. (OTC PINK: MRES), a vanguard entity at the forefront of nutraceutical...
► Artikel lesen
15.11.23Institute of BioMedical Research Corp.: MRES: M2Bio Sciences Expands Global Presence with New Offices in Dubai Science Park373CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 15, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES): A pioneering force in nutraceutical biotechnology, specializing in alternative plant-based...
► Artikel lesen
14.11.23Institute of BioMedical Research Corp.: MRES: M2Bio Sciences Marks Milestone Expansion with Launch of Los Angeles Office348CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 14, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in alternative...
► Artikel lesen
03.11.23Institute of BioMedical Research Corp.: African Ginger Patented for Influenza and SARS-CoV-2 Treatment: Insights from M2Bio Sciences Research Chair324CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / November 3, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology specializing in alternative...
► Artikel lesen
12.10.23Institute of BioMedical Research Corp.: M2MMA Announces 2024 Fight Schedule and Appoints CEO917CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / October 12, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alternative...
► Artikel lesen
02.10.23Institute of BioMedical Research Corp.: M2Bio Sciences Chair, Prof Maharaj, to Deliver Keynote Address on Cutting-Edge Biotechnology Advancements469CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / October 2, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in alternative...
► Artikel lesen
21.09.23Institute of BioMedical Research Corp.: M2Bio Sciences Closes JDAX Acquisition512CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 21, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in...
► Artikel lesen
15.09.23Institute of BioMedical Research Corp.: M2Bio Sciences Pharmacology & Clinical Application of CBD519CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 15, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in...
► Artikel lesen
13.09.23Institute of BioMedical Research Corp.: M2Bio-Discovery Centre for AI-Driven Phytomedicine Research: Update586CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / September 13, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES), a vanguard entity at the forefront of nutraceutical biotechnology, specializing in...
► Artikel lesen
17.08.23Institute of BioMedical Research Corp.: M2bio Sciences Announces Launch of Exclusive MMA Organization386CAPE TOWN, SOUTH AFRICA / ACCESSWIRE / August 17, 2023 / Institute of Biomedical Research Corp. (OTC PINK:MRES) ("Institute of Biomedical Research" or the "Company"), a pioneering force in nutraceutical...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1